Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1332 of 5804
-
New pill shows promise for advanced breast cancer – Real-World trial underway
Disease control Recruiting nowThis study is a multi-center, observational, real-world study. We planned to recruit 420 HR+ locally advanced or metastatic breast cancer patients who had received or had not received prior systemic therapy. All patients included in the analysis were receiving or planning to rece…
Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:07 UTC
-
Blood test may let lung transplant patients ditch antiviral drugs sooner
Disease control Recruiting nowThe purpose of this study is to determine the safety and feasibility of using a laboratory test to guide duration of antiviral prophylaxis with valganciclovir (medication used to prevent viral infections) after lung transplant. The laboratory test, inSIGHT™ CMV T Cell Immunity Pa…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Braces without the spots: antiseptic solution may protect teeth during orthodontics
Prevention OngoingThe goal of this clinical trial is to learn if topical application on the all surface of 10% Povidone Iodine (Povi-One) in healthy participants in transitional or permanent dentition (10-17 y) prevents new white spot lesions in the maxillary anterior teeth at 1 year of follow-up.…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Balloon trick after clot removal may shield the brain
Disease control CompletedThe goal of this clinical trial is to determine if direct ischemic post-conditioning (IPostC) can alleviate ischemic-reperfusion injury (I/R) in patients who have undergone endovascular thrombectomy (EVT). Additionally, the study aims to explore the underlying mechanisms of direc…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could vitamin B3 tame gut inflammation?
Disease control Recruiting nowDouble-blind, randomised, placebo-controlled phase II / III trial evaluating efficacy and safety of two different doses (2 g/d or 3 g/d) of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) compared to placebo in patients with ulcerative colitis (UC). The intended ther…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New scan could spot cancer marker better than current tests
Diagnosis Recruiting nowThis phase II study aims to confirm the diagnostic performance and accuracy of 68Ga-ABS011 PET/CT in determining the HER2 expression status, and to evaluate 68Ga-ABS011's ability to drive changes in therapeutic treatment. 68Ga-ABS011 will be compared to the current standard of ca…
Phase: PHASE2 • Sponsor: Abscint NV/SA • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Stroke study: can a quick blood flow pause boost brain recovery?
Disease control CompletedThis clinical trial will evaluate whether on-site ischemic postconditioning (IPostC) improves outcomes in acute stroke patients receiving endovascular thrombectomy (EVT) and explore its mechanisms. The investigators aim to answer: (1) Is on-site IPostC effective compared to EVT a…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Phone calls that save lives: study tests social bond theory against suicide
Knowledge-focused Recruiting nowThe World Health Organization (WHO) estimates, with 800,000 annual deaths, that suicide is the second leading cause of death in people aged 10 to 44 and thus recognizes suicide prevention as a public health priority. The psychological impact of the COVID-19 pandemic, the social i…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Could a 30-Minute ZAP during surgery help heal nerves?
Disease control ENROLLING_BY_INVITATIONDuring the process of nerve microsurgical reconstruction, 30 minutes of electrical stimulation is applied to the distal end of the damaged nerve to assess its potential benefits for nerve regeneration, functional recovery, slowing down the degeneration at the neuromuscular juncti…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a single pill replace a cocktail of Anti-Rejection drugs after liver transplant?
Disease control Recruiting nowThis is a study to determine the safety, efficacy, and tolerability of taking away the anti-rejection medicine, tacrolimus, in liver transplant recipients in conjunction with everolimus monotherapy to preserve renal function. Two hundred - seventy (270) subjects will be randomize…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New wearable device helps Parkinson's patients unfreeze their steps
Symptom relief CompletedThe proposed system (haptic module and insole device) for daily in-community use that detects the occurrence of freezing of gait (FOG) in people with Parkinson's disease (PD). and triggers external cueing stimuli to unfreeze the individual. The purpose of the overall Phase II stu…
Sponsor: HealthPartners Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New inhaler aims to cut dangerous lung Flare-Ups in bronchiectasis patients
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebulizer over at least 24 weeks, compared to placebo, in subjects with non-cystic fib…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New heart valve replacement without open surgery shows early promise
Disease control Recruiting nowProspective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Phase: NA • Sponsor: TRiCares • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Sound waves instead of surgery: new device tested for vein disease
Disease control OngoingThe goal of this clinical trial is to learn if the Sonablate High Intensity Focused Ultrasound device can be safely used to treat patients with Chronic Venous Incompetence (CVI) including those with venous malformations of the periphery meaning legs, abdomen, chest or back. Examp…
Phase: NA • Sponsor: Sonablate • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill aims to ease fatigue and brain fog in rare mitochondrial disease
Disease control CompletedPRIZM is a Phase 2b randomized, double-blind, placebo-controlled, 3-treatment, 2-period, crossover study evaluating the efficacy and safety of oral zagociguat 15 and 30 mg vs. placebo when administered daily for 12 weeks in participants with genetically and phenotypically defined…
Phase: PHASE2 • Sponsor: Tisento Therapeutics • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can eye contact training help toddlers with autism? new trial tests Parent-Led therapy
Symptom relief OngoingPurpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 month…
Phase: NA • Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New dual therapy aims to beat stomach bug with fewer pills
Disease control Recruiting nowEradication of HP can significantly improve and reduce HP-related diseases. A 10-14 day quadruple regimen containing bismuth as first-line treatment, achieving an eradication rate of more than 85%. However, some disadvantages of these quadruple regimens, such as severe adverse re…
Phase: PHASE3 • Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New MRI scan aims to detect hidden brain injuries in soccer players
Diagnosis Recruiting nowChronic traumatic encephalopathy (CTE) is a neurodegenerative disease described in boxing, but also in contact sports such as American football. Soccer, due to repeated headers, could also be associated, albeit to a lesser degree, with the development of this type of pathology. …
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New chemo combo shows promise in breast cancer trial
Disease control CompletedThe purpose of this study is to compare the safety and efficacy of bi-weekly WH002(Paclitaxel Medium and Long Chain Fat Emulsion Injection,Cholesterol Bound) vs Paclitaxel both followed by bi-weekly Epirubicin and Cyclophosphamide as neoadjuvant treatment in women with HER2-negat…
Phase: PHASE2 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill aims to quiet tourette tics in landmark trial
Symptom relief OngoingThis study is designed to evaluate the efficacy and safety of gemlapodect (NOE-105) on reducing tics associated with Tourette Syndrome (TS) in adults with TS. Adolescents will be enrolled after a sentinel cohort of adults is complete.
Phase: PHASE2 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC